Sugi Predict

Sugi Predict / Compounds / SCHEMBL29604989

SCHEMBL29604989

SCHEMBL29604989

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.57
▸ KDM1A O60341 3/20 0.57
▸ MAPK8 P45983 1/20 0.56
▸ MAPK9 P45984 1/20 0.56
▸ MAPK10 P53779 1/20 0.56
▸ GLP1R P43220 4/20 0.55
▸ VIPR1 P32241 3/20 0.55
▸ VIPR2 P41587 3/20 0.55
▸ CRHR1 P34998 1/20 0.54
▸ CRHR2 Q13324 1/20 0.54
▸ NPY2R P49146 4/20 0.54
▸ NPY4R P50391 4/20 0.54
▸ NPY5R Q15761 4/20 0.54
▸ NPY1R P25929 3/20 0.54
▸ RAMP1 O60894 1/20 0.53
▸ RAMP2 O60895 1/20 0.53
▸ RAMP3 O60896 1/20 0.53
▸ CALCR P30988 1/20 0.53
▸ CALCRL Q16602 1/20 0.53
▸ MAOB P27338 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31182785 0.92 MAPK8 (0.62) KEAP1MAPK8MAPK9MAPK10GLP1R
SCHEMBL29868686 0.89 NPY2R (0.68) KDM1AMAPK8MAPK9MAPK10NPY2R
SCHEMBL31332072 0.89 GLP1R (0.56) GLP1RVIPR1VIPR2NPY4RNPY5R
SCHEMBL30950134 0.86 KEAP1 (0.66) KEAP1MAPK8MAPK9MAPK10GLP1R
SCHEMBL30168770 0.86 F2 (0.58) KEAP1KDM1AGLP1RNPY2RNPY4R
SCHEMBL29854508 0.86 VIPR1 (0.62) GLP1RVIPR1VIPR2
SCHEMBL30168694 0.85 KEAP1 (0.59) KEAP1KDM1AMAPK8MAPK9MAPK10
SCHEMBL29516852 0.85 VIPR1 (0.70) GLP1RVIPR1VIPR2
SCHEMBL29430436 0.85 VIPR1 (0.70) GLP1RVIPR1VIPR2
SCHEMBL16507837 0.85 NPY4R (0.57) GLP1RNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240374689-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME LONGEVITY BIOTECH, INC. 2024-11-14 — — US disclosed
US-20240325487-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2024-10-03 — — US disclosed
US-11813304-B2 Compounds and methods for inhibiting phosphate transport ARDELYX, INC. (US) 2023-11-14 — — US disclosed
EP-3884935-B1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX INC (US) 2023-06-14 — — EP disclosed
CN-114404588-A Compounds and methods for inhibiting phosphate transport 阿德利克斯公司 2022-04-29 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240325487-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC34A3, SLC34A2, SLC34A1 KEAP1 3244/4885KDM1A 4606/4885MAPK8 1993/4885
US-11813304-B2 Compounds and methods for inhibiting phosphate transport SLC34A3, SLC34A2, SLC34A1 KEAP1 3244/4885KDM1A 4606/4885MAPK8 1993/4885
US-20240374689-A1 HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME SCTR, GIPR, APLNR KEAP1 3945/4885KDM1A 4842/4885MAPK8 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback